
David Chris Pound MD
Advanced Endoscopic Interventional
Clinical Professor of Medicine, Indiana University
Join to view full profile
8051 S Emerson AveSte 200Indianapolis, IN 46237
Phone+1 317-865-2955
Fax+1 317-865-2944
Dr. Pound is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineFellowship, Gastroenterology, 1983 - 1985
Indiana University School of MedicineResidency, Internal Medicine, 1980 - 1983
Indiana University School of MedicineClass of 1980
Certifications & Licensure
IN State Medical License 1980 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2012-2017
Clinical Trials
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 49 citationsMulticentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study).Brooks D. Cash, Mark R Fleisher, Steven Fern, Elizabeth Rajan, Robyn Haithcock
Gut. 2021-11-01 - 15 citationsMulticenter, randomized study to optimize bowel preparation for colon capsule endoscopy.David Kastenberg, Wilmot C Burch, David P. Romeo, Pankaj K. Kashyap, David Pound
World Journal of Gastroenterology. 2017-12-28 - 49 citationsEfficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.Edward Gane, Kris V. Kowdley, David Pound, Catherine A.M. Stedman, M. Davis
Gastroenterology. 2016-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









